380 related articles for article (PubMed ID: 21390519)
61. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
62. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
[TBL] [Abstract][Full Text] [Related]
63. Prognostic implications of serum microRNA-21 in colorectal cancer.
Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
[TBL] [Abstract][Full Text] [Related]
64. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C
Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779
[TBL] [Abstract][Full Text] [Related]
66. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
[TBL] [Abstract][Full Text] [Related]
67. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
Wang G; Shen N; Cheng L; Lin J; Li K
Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
[TBL] [Abstract][Full Text] [Related]
68. Diagnostic Value Investigation and Bioinformatics Analysis of miR-31 in Patients with Lymph Node Metastasis of Colorectal Cancer.
Zhang WW; Ming XL; Rong Y; Huang CQ; Weng H; Chen H; Bian JM; Wang FB
Anal Cell Pathol (Amst); 2019; 2019():9740475. PubMed ID: 31934534
[TBL] [Abstract][Full Text] [Related]
69. Expression and clinical significance of microRNA-376a in colorectal cancer.
Mo ZH; Wu XD; Li S; Fei BY; Zhang B
Asian Pac J Cancer Prev; 2014; 15(21):9523-7. PubMed ID: 25422250
[TBL] [Abstract][Full Text] [Related]
70. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
71. Transcatheter arterial infusion chemotherapy increases expression level of miR-142-5p in stage III colorectal cancer.
Shi D; Zhai B; Zheng Y; Ren R; Han M; Wang X
Indian J Cancer; 2015 Dec; 52 Suppl 2():e47-55. PubMed ID: 26728674
[TBL] [Abstract][Full Text] [Related]
72. Evaluation of miR-720 prognostic significance in patients with colorectal cancer.
Wang X; Kuang Y; Shen X; Zhou H; Chen Y; Han Y; Yuan B; Zhou J; Zhao H; Zhi Q; Xue X
Tumour Biol; 2015 Feb; 36(2):719-27. PubMed ID: 25286763
[TBL] [Abstract][Full Text] [Related]
73. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
[TBL] [Abstract][Full Text] [Related]
74. Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
Zhang D; Zhao L; Shen Q; Lv Q; Jin M; Ma H; Nie X; Zheng X; Huang S; Zhou P; Wu G; Zhang T
Int J Cancer; 2017 May; 140(10):2298-2309. PubMed ID: 28213952
[TBL] [Abstract][Full Text] [Related]
75. MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
Chen Y; Zhang Y; He J; Fu Y; Lin C; Li X
Oncol Rep; 2017 Mar; 37(3):1646-1652. PubMed ID: 28098895
[TBL] [Abstract][Full Text] [Related]
76. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
77. Clinicopathologic and prognostic relevance of miR-1256 in colorectal cancer: a preliminary clinical study.
Liu ZY; Yang L; Chang HY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7704-7709. PubMed ID: 30536313
[TBL] [Abstract][Full Text] [Related]
78. miR-206 is an independent prognostic factor and inhibits tumor invasion and migration in colorectal cancer.
Sun P; Sun D; Wang X; Liu T; Ma Z; Duan L
Cancer Biomark; 2015; 15(4):391-6. PubMed ID: 26406866
[TBL] [Abstract][Full Text] [Related]
79. A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival.
Pecqueux M; Liebetrau I; Werft W; Dienemann H; Muley T; Pfannschmidt J; Müssle B; Rahbari N; Schölch S; Büchler MW; Weitz J; Reissfelder C; Kahlert C
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775664
[TBL] [Abstract][Full Text] [Related]
80. MicroRNA-630 is a prognostic marker for patients with colorectal cancer.
Chu D; Zheng J; Li J; Li Y; Zhang J; Zhao Q; Wang W; Ji G
Tumour Biol; 2014 Oct; 35(10):9787-92. PubMed ID: 24981248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
